We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$158M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$70.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$34.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$33.9M
5
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$22.9M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDYG icon
3176
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.96B
$45.9K ﹤0.01%
546
-2,253
-80% -$190K
ALXO icon
3177
ALX Oncology
ALXO
$278M
$45.7K ﹤0.01%
7,579
+2,833
+60% +$34.8K
RBLX icon
3178
Roblox
RBLX
$25.4B
$45.7K ﹤0.01%
1,227
-13,163
-91% -$469K
THRD
3179
DELISTED
Third Harmonic Bio
THRD
$45.7K ﹤0.01%
3,512
+3,162
+903% +$39.1K
AROW icon
3180
Arrow Financial
AROW
$725M
$45.6K ﹤0.01%
1,750
+1,733
+10,194% +$41.5K
BALY icon
3181
Bally's
BALY
$671M
$45.5K ﹤0.01%
3,797
+1,026
+37% +$13.1K
CAPR icon
3182
Capricor Therapeutics
CAPR
$243M
$45.4K ﹤0.01%
9,524
+4,691
+97% +$26.2K
CX icon
3183
Cemex
CX
$16.2B
$45.4K ﹤0.01%
7,098
-16,943
-70% -$130K
SFST icon
3184
Southern First Bancshares
SFST
$607M
$45.3K ﹤0.01%
1,549
+1,452
+1,497% +$39.9K
FAAR icon
3185
First Trust Alternative Absolute Return Strategy ETF
FAAR
$198M
$45.2K ﹤0.01%
+1,592
New +$45.5K
EGHT icon
3186
8x8 Inc
EGHT
$290M
$45.1K ﹤0.01%
20,313
+17,647
+662% +$42.9K
PERI icon
3187
Perion Network
PERI
$377M
$44.8K ﹤0.01%
5,371
+5,357
+38,264% +$65K
CLAR icon
3188
Clarus
CLAR
$141M
$44.8K ﹤0.01%
6,658
-5,531
-45% -$36.5K
ELDN icon
3189
Eledon Pharmaceuticals
ELDN
$291M
$44.8K ﹤0.01%
16,958
+11,284
+199% +$26.9K
DADA
3190
DELISTED
Dada Nexus
DADA
$44.4K ﹤0.01%
+35,270
New +$63.4K
NGVC icon
3191
Vitamin Cottage Natural Grocers
NGVC
$632M
$44.4K ﹤0.01%
2,093
+1,740
+493% +$33.1K
MODV
3192
DELISTED
ModivCare
MODV
$44.3K ﹤0.01%
1,688
-2,952
-64% -$74.7K
NVS icon
3193
Novartis
NVS
$290B
$44.3K ﹤0.01%
416
-3,357
-89% -$337K
AXIA
3194
DELISTED
AXIA Energia
AXIA
$44.2K ﹤0.01%
8,690
+6,553
+307% +$37.5K
NIO icon
3195
NIO
NIO
$11.4B
$44.2K ﹤0.01%
10,633
-49,075
-82% -$232K
ALCO icon
3196
Alico
ALCO
$308M
$44.2K ﹤0.01%
1,704
+1,578
+1,252% +$42.7K
CARE icon
3197
Carter Bankshares
CARE
$717M
$44.1K ﹤0.01%
2,918
+2,646
+973% +$33.1K
VT icon
3198
Vanguard Total World Stock ETF
VT
$81.4B
$43.9K ﹤0.01%
390
+254
+187% +$28K
NEWT icon
3199
NewtekOne
NEWT
$370M
$43.9K ﹤0.01%
3,494
+2,436
+230% +$30K
PDSB icon
3200
PDS Biotechnology
PDSB
$13.5M
$43.8K ﹤0.01%
14,945
+10,792
+260% +$34.5K
126 127
128
129 130

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.